GeneDx price target raised to $24 from $14 at TD Cowen
The Fly

GeneDx price target raised to $24 from $14 at TD Cowen

TD Cowen raised the firm’s price target on GeneDx to $24 from $14 and keeps a Buy rating on the shares. The firm said the company’s turnaround story is well underway following a strong beat and raise as momentum continues to build from revenue to cash burn and Cowen now sees a clear path to profitability in 2024.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App